Abstract
Many families with multiple cases of ovarian cancer, breast cancer, or both segregate inherited mutations in one allele of the tumor suppressor gene BRCA1. Genetic testing is used to assess cancer risk; however, testing can detect missense DNA alterations, called unclassified variants, of unknown functional and biological significance with uncertain risk implications. Some missense variants at the transcriptional activation domain of BRCA1 of cancer patients inactivate transcriptional activity of BRCA1, providing evidence that they are deleterious. We identified the variants V1804D and M1628T at the transcriptional activation domain of BRCA1 of two ovarian cancer patients without a family history of ovarian or breast cancer. To test if these residues are critical for transcriptional activation, we created V1804D and M1628T independently in BRCA1 cDNA via site-directed mutagenesis in a mammalian expression vector, pcDNA3.1. Wild-type, mutant, and empty vector constructs were tested in human kidney 293 cells using a p53-responsive luciferase reporter. M1628T had the same transcriptional activity as wild-type BRCA1 but V1804D and the empty vector control showed a 60% reduction. This indicates that V1804D is deleterious but M1628T ...Continue Reading
References
Oct 7, 1994·Science·Y MikiW Ding
Feb 15, 1995·JAMA : the Journal of the American Medical Association·D Shattuck-EidensM Erdos
Oct 7, 1994·Science·P A FutrealY Miki
Aug 22, 1996·Nature·M S Chapman, I M Verma
Jan 1, 1996·Human Mutation·F J Couch, B L Weber
Jan 1, 1996·Human Mutation
Nov 26, 1996·Proceedings of the National Academy of Sciences of the United States of America·A N MonteiroH Hanafusa
Apr 17, 1997·The New England Journal of Medicine·J F StrattonB A Ponder
Sep 20, 1997·Nature·K SomasundaramW S El-Deiry
Oct 27, 1997·American Journal of Human Genetics·A N MonteiroH Hanafusa
Apr 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·T OuchiH Hanafusa
Feb 25, 2000·Cancer Genetics and Cytogenetics·H TworekR A DiCioccio
Aug 18, 2000·Mutation Research·T HuytonP S Freemont
Feb 7, 2001·Human Molecular Genetics·J Vallon-ChristerssonA N Monteiro
May 2, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B N PeshkinC Isaacs
Jul 24, 2001·Oncogene·B J OrelliD K Bishop
Sep 24, 2004·American Journal of Epidemiology·V McGuireA S Whittemore
Citations
Jan 10, 2012·Breast Cancer Research and Treatment·Michelle G RathBarbara Burwinkel
Jun 1, 2005·Journal of Medical Genetics·P K LovelockUNKNOWN kConFab Investigators
Nov 27, 2007·Breast Cancer Research : BCR·Paul K LovelockMelissa A Brown
Mar 2, 2011·Breast Cancer Research : BCR·Kirsi M KuusistoSatu-Leena Sallinen
Apr 15, 2014·PloS One·Dale L BodianJohn E Niederhuber
Oct 20, 2015·Molecular Diagnosis & Therapy·Elisabete Weiderpass, Jerzy E Tyczynski
Oct 10, 2007·American Journal of Human Genetics·Douglas F EastonDavid E Goldgar
Feb 21, 2006·Cancer Research·Georgia Chenevix-TrenchUNKNOWN kConFab Investigators